Literature DB >> 30444823

The authors reply.

Tyree H Kiser1, Ellen L Burnham, Brendan Clark, P Michael Ho, Richard R Allen, Marc Moss, R William Vandivier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30444823      PMCID： PMC6410742          DOI： 10.1097/CCM.0000000000003453

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  4 in total

1.  Half-Dose Versus Full-Dose Alteplase Therapy in Pulmonary Embolism: Does Half Dose Really Lose?

Authors:  Qi Jin; Qin Luo; Zhihui Zhao; Zhihong Liu
Journal:  Crit Care Med       Date:  2018-12       Impact factor: 7.598

2.  Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism.

Authors:  Stavros V Konstantinides; Eric Vicaut; Thierry Danays; Cecilia Becattini; Laurent Bertoletti; Jan Beyer-Westendorf; Helene Bouvaist; Francis Couturaud; Claudia Dellas; Daniel Duerschmied; Klaus Empen; Emile Ferrari; Nazzareno Galiè; David Jiménez; Maciej Kostrubiec; Matija Kozak; Christian Kupatt; Irene M Lang; Mareike Lankeit; Nicolas Meneveau; Massimiliano Palazzini; Piotr Pruszczyk; Matteo Rugolotto; Aldo Salvi; Olivier Sanchez; Sebastian Schellong; Bozena Sobkowicz; Guy Meyer
Journal:  J Am Coll Cardiol       Date:  2017-03-28       Impact factor: 24.094

3.  Fibrinolysis for patients with intermediate-risk pulmonary embolism.

Authors:  Guy Meyer; Eric Vicaut; Thierry Danays; Giancarlo Agnelli; Cecilia Becattini; Jan Beyer-Westendorf; Erich Bluhmki; Helene Bouvaist; Benjamin Brenner; Francis Couturaud; Claudia Dellas; Klaus Empen; Ana Franca; Nazzareno Galiè; Annette Geibel; Samuel Z Goldhaber; David Jimenez; Matija Kozak; Christian Kupatt; Nils Kucher; Irene M Lang; Mareike Lankeit; Nicolas Meneveau; Gerard Pacouret; Massimiliano Palazzini; Antoniu Petris; Piotr Pruszczyk; Matteo Rugolotto; Aldo Salvi; Sebastian Schellong; Mustapha Sebbane; Bozena Sobkowicz; Branislav S Stefanovic; Holger Thiele; Adam Torbicki; Franck Verschuren; Stavros V Konstantinides
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

4.  Half-Dose Versus Full-Dose Alteplase for Treatment of Pulmonary Embolism.

Authors:  Tyree H Kiser; Ellen L Burnham; Brendan Clark; P Michael Ho; Richard R Allen; Marc Moss; R William Vandivier
Journal:  Crit Care Med       Date:  2018-10       Impact factor: 7.598
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.